Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7288705

Concept As at
2024-11-30
2024-06-01 to
2024-11-30
2023-06-01 to
2024-05-31
As at
2024-05-31
As at
2023-11-30
2023-06-01 to
2023-11-30
Key financial data of group
Business results of group
Net sales
505,936,000,000 JPY
964,989,000,000 JPY
476,430,000,000 JPY
Ordinary profit (loss)
21,777,000,000 JPY
34,299,000,000 JPY
17,346,000,000 JPY
Profit (loss) attributable to owners of parent
14,428,000,000 JPY
24,454,000,000 JPY
11,587,000,000 JPY
Comprehensive income
14,423,000,000 JPY
24,516,000,000 JPY
11,585,000,000 JPY
Net assets
243,486,000,000 JPY
231,442,000,000 JPY
220,889,000,000 JPY
Total assets
486,571,000,000 JPY
476,546,000,000 JPY
436,155,000,000 JPY
Basic earnings (loss) per share
182.05
308.61
146.27
Diluted earnings per share
Equity-to-asset ratio
0.500 xbrli:pure
0.486 xbrli:pure
0.506 xbrli:pure
Net cash provided by (used in) operating activities
15,087,000,000 JPY
55,175,000,000 JPY
16,948,000,000 JPY
Net cash provided by (used in) investing activities
-22,511,000,000 JPY
-57,329,000,000 JPY
-28,545,000,000 JPY
Net cash provided by (used in) financing activities
-5,748,000,000 JPY
8,527,000,000 JPY
-4,634,000,000 JPY
Cash and cash equivalents
39,129,000,000 JPY
52,301,000,000 JPY
29,696,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.